Trials / Completed
CompletedNCT00926393
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
A Phase IV, Multi-center, Double-blind, Double-dummy, Randomized, Parallel-group Study to Compare the Tolerability of Quetiapine Fumarate Immediate Release (Seroquel IR) With Quetiapine Fumarate Extended Release (Seroquel XR) During Initial Dose Escalation in Patients With Bipolar Depression
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the sedation profile one hour after dose administration between Seroquel IR and Seroquel XR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Quetiapine Immediate Release | Oral, 3 tablets daily: (2 x 25 mg + 1 x 50 mg) at one time each day |
| DRUG | Quetiapine Extended Release | Oral, 3 tablets daily: (2 x 25 mg + 1 x 50 mg) at one time each day |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2009-06-23
- Last updated
- 2011-05-11
- Results posted
- 2011-03-31
Source: ClinicalTrials.gov record NCT00926393. Inclusion in this directory is not an endorsement.